Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial
Abstract Background While the introduction of checkpoint inhibitors (CPIs) as standard of care treatment for various tumor types has led to considerable improvements in clinical outcome, the majority of patients still fail to respond. Preclinical data suggest that stereotactic body radiotherapy (SBR...
Main Authors: | Mathieu Spaas, Nora Sundahl, Eva Hulstaert, Vibeke Kruse, Sylvie Rottey, Daan De Maeseneer, Veerle Surmont, Annabel Meireson, Lieve Brochez, Dries Reynders, Els Goetghebeur, Robbe Van den Begin, Dirk Van Gestel, Vincent Renard, Piet Dirix, Pieter Mestdagh, Piet Ost |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-08088-w |
Similar Items
-
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response
by: Nora Sundahl, et al.
Published: (2017-06-01) -
Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial
by: Katrien De Wolf, et al.
Published: (2017-09-01) -
Nonkeratinizing Carcinoma of the Sinonasal Tract: A Diagnosis of Confusing Nomenclature
by: Nur Hashima Abdul Rashid, et al.
Published: (2011-12-01) -
Correlación clínico-histológica de pacientes operados de cáncer de piel no melanocítico en la provincia de Cienfuegos, año 200
by: María Dolores Castillo Menéndez, et al.
Published: (2003-06-01) -
Giant basal cell carcinoma associated with vitiligo
by: Luiza Fiszon‐Cerqueira, et al.
Published: (2019-09-01)